Point72 Asset Management, L.P. - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 90 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.5%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q3 2020$1,567,000
-2.3%
14,100
-10.2%
0.01%
-20.0%
Q2 2020$1,604,000
+140.5%
15,700
+173.9%
0.01%
+150.0%
Q4 2019$667,000
-67.7%
5,731
-68.3%
0.00%
-69.2%
Q3 2019$2,066,000
-68.1%
18,051
-73.4%
0.01%
-61.8%
Q2 2019$6,477,000
+405.6%
67,966
+426.9%
0.03%
+580.0%
Q2 2018$1,281,00012,9000.01%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q4 2020
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 149,457$11,773,0006.29%
INDUS CAPITAL PARTNERS, LLC 330,339$26,021,0002.54%
Perpetual Ltd 129,799$10,215,0001.32%
Black Creek Investment Management Inc. 396,525$31,234,0001.18%
RUDMAN ERROL M 28,701$2,261,0001.10%
COMGEST GLOBAL INVESTORS S.A.S. 635,752$50,078,0001.09%
Antipodean Advisors LLC 15,000$1,182,0000.96%
Hillhouse Capital Management 618,391$48,711,0000.83%
JUPITER ASSET MANAGEMENT LTD 215,866$17,004,0000.49%
Temasek Holdings (Private) Ltd 990,000$77,982,0000.48%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders